Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NHLBI Type II Coronary Intervention Study
NCT00000594Phase 3Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Nov 1971
- Modality
- Small Molecules, Device-based Delivery
01
Overview
Phase 3, randomised, double-blind trial in coronary artery disease (CAD) and hypercholesterolemia comparing Cholestyramine with Placebo (2 arms). Primary endpoints: Progression of coronary artery disease on angiography at 5 years and New myocardial infarction or death at 5 years. Started Nov 1971; status: completed.
02
Drugs
cholestyramine
03
Conditions
coronary artery disease (CAD)hypercholesterolemia
Beyond the preview
Go deeper on NCT00000594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000594.